ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
百奧賽圖-B
23.800
0.000
手動刷新
成交量:
23.05萬
成交額:
544.85萬
市值:
95.06億
市盈率:
258.83
高:
24.200
開:
23.800
低:
23.080
收:
23.800
52周最高:
31.340
52周最低:
5.600
股本:
3.99億
香港流通股本:
1.11億
量比:
0.72
換手率:
0.21%
股息:
- -
股息率:
- -
每股收益(LYR):
0.092
淨資產收益率:
16.11%
總資產收益率:
6.20%
市淨率:
9.77
市盈率(LYR):
258.83
市銷率:
7.32
資料載入中...
總覽
公司
新聞
公告
百奧賽圖IPO過會:半年營收6.2億擬募資12億 沈月雷控制27%投票權
雷递
·
09/24
百奧賽圖-B(02315)建議A股發行獲上交所科創板上市委員會批准
智通财经
·
09/24
百奧賽圖科創板過會!「模式動物三巨頭」或將齊聚A股
大河财立方
·
09/24
百奧賽圖科創板IPO過會 從「實驗小鼠」到佈局全產業鏈
e公司
·
09/24
H+A淨利潤2300萬的CRO公司,科創板過會!
和诚咨询
·
09/24
百奧賽圖:從「千鼠萬抗」到全球合作,中國Biotech的出海範本
新浪证券
·
09/23
H股上市後股價暴跌八成,百奧賽圖迎來科創板IPO大考
中金在线
·
09/23
百奧賽圖-B盤中異動 早盤股價大跌5.04%報26.020港元
市场透视
·
09/23
"A+H雙市套利"背後的困惑:百奧賽圖募資初衷與上市規劃,為何難逃業界的深層質疑?
中金在线
·
09/23
百奧賽圖—IPO反饋問題
中金在线
·
09/23
H+A的百奧賽圖募資的隨意性與對科研人員卸磨殺驢來美化報表?
新浪财经
·
09/22
百奧賽圖IPO:募資縮水超7億,要孖展11.85億,實控人外債不低
短平快解读
·
09/22
賣小鼠的百奧塞圖衝刺「A+H」,實控人夫婦竟「預製」股權質押?
银莕财经
·
09/22
百奧賽圖IPO:因專利侵權被起訴,獨董因信披違規被出具警示函
新浪财经
·
09/22
百奧賽圖「雙業務線」持續放量:多項國際合作開啓新階段
新浪证券
·
09/22
錢燒光就回A?H股「基因編輯第一股」百奧賽圖帶着5個研發人員勇闖科創板IPO
中金在线
·
09/22
百奧賽圖IPO:一面是A+H「光輝」,一面是大量人員「優化」,扭虧為盈的背後,心酸的「研發耗材」
中金在线
·
09/22
IPO研究丨本週4家上會,「基因編輯第一股」回A待審
瑞财经
·
09/22
今日1新股申購!格力、美的「小夥伴」將登陸北交所
e公司
·
09/22
百奧賽圖-B09月19日主力淨流出0.7萬元 散户資金買入
市场透视
·
09/19
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02315/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02315","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02315\",,,,,undefined,":{"symbol":"02315","market":"HK","secType":"STK","nameCN":"百奧賽圖-B","latestPrice":23.8,"timestamp":1761034089105,"preClose":23.8,"halted":0,"volume":230500,"delay":0,"floatShares":110781920,"shares":399398420,"eps":0.09196343435552308,"marketStatus":"已收盤","change":0,"latestTime":"10-21 16:08:09","open":23.8,"high":24.2,"low":23.08,"amount":5448520,"amplitude":0.047059,"askPrice":23.9,"askSize":500,"bidPrice":23.8,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":0.36341346860380175,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1761096600000},"marketStatusCode":5,"adr":0,"listingDate":1661961600000,"exchange":"SEHK","adjPreClose":23.8,"openAndCloseTimeList":[[1761010200000,1761019200000],[1761022800000,1761033600000]],"volumeRatio":0.718347,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02315\",,,,,undefined,":{"symbol":"02315","floatShares":110781920,"roa":"6.20%","roe":"16.11%","lyrEps":0.091952,"volumeRatio":0.718347,"shares":399398420,"dividePrice":0,"high":24.2,"amplitude":0.047059,"preClose":23.8,"low":23.08,"week52Low":5.6,"pbRate":"9.77","psRate":"7.32","week52High":31.34,"institutionHeld":0,"latestPrice":23.8,"committee":0.333333,"eps":0.09195152643767487,"divideRate":0,"volume":230500,"delay":0,"ttmEps":0.36336641188218843,"open":23.8,"prevYearClose":8.5,"prevWeekClose":22.76,"prevMonthClose":28.48,"prevQuarterClose":28.48,"fiveDayClose":22.66,"twentyDayClose":27.5,"sixtyDayClose":20.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02315\",params:#limit:5,,,undefined,":[{"date":"2025-08-28","symbol":"02315","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756344600000,"name":null,"time":"","dateTimestamp":1756310400000,"actualEps":null},{"date":"2025-03-26","symbol":"02315","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"盤後","dateTimestamp":1742918400000,"actualEps":null},{"market":"HK","date":"2024-08-28","symbol":"02315","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1724774400000,"reportTimeType":"post","actualEps":null},{"date":"2024-03-27","symbol":"02315","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711503000000,"name":null,"time":"","dateTimestamp":1711468800000,"actualEps":null},{"date":"2023-08-28","symbol":"02315","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693186200000,"name":null,"time":"","dateTimestamp":1693152000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02315\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02315\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1743782400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02315\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02315","date":"2025-10-20","current":65.61317,"percent":0.828794,"low":-25.760101,"twenty":-15.119968,"median":-9.315346,"eighty":-5.897815,"high":292.060693,"avg":21.342254,"sd":76.405971,"marketCap":9505682396},"quantilePoints":[{"date":"2022-09-02","current":-17.320141,"twenty":-17.183465,"median":-16.97845,"eighty":-16.773436,"marketCap":10750256182},{"date":"2022-09-09","current":-16.423987,"twenty":-16.725792,"median":-16.549247,"eighty":-16.380597,"marketCap":10155223552},{"date":"2022-09-16","current":-16.318147,"twenty":-16.63676,"median":-16.36975,"eighty":-16.316556,"marketCap":9996548184},{"date":"2022-09-23","current":-16.637534,"twenty":-16.675139,"median":-16.58177,"eighty":-16.318147,"marketCap":9996548184},{"date":"2022-09-30","current":-16.676297,"twenty":-16.685959,"median":-16.63676,"eighty":-16.318147,"marketCap":10464238604},{"date":"2022-10-07","current":-16.709082,"twenty":-16.759103,"median":-16.644605,"eighty":-16.32635,"marketCap":10484208525},{"date":"2022-10-14","current":-17.016883,"twenty":-16.759103,"median":-16.64107,"eighty":-16.343742,"marketCap":10564088209},{"date":"2022-10-21","current":-17.166611,"twenty":-17.031627,"median":-16.675139,"eighty":-16.354867,"marketCap":10584058130},{"date":"2022-10-28","current":-16.904053,"twenty":-17.031627,"median":-16.675441,"eighty":-16.36536,"marketCap":10404328841},{"date":"2022-11-04","current":-16.612618,"twenty":-17.082341,"median":-16.676297,"eighty":-16.369306,"marketCap":10324449157},{"date":"2022-11-11","current":-16.306635,"twenty":-17.029879,"median":-16.67602,"eighty":-16.36536,"marketCap":10224599552},{"date":"2022-11-18","current":-16.746191,"twenty":-17.082341,"median":-16.685959,"eighty":-16.369306,"marketCap":10464238604},{"date":"2022-11-25","current":-16.976752,"twenty":-17.082341,"median":-16.684366,"eighty":-16.41314,"marketCap":10524148367},{"date":"2022-12-02","current":-16.467053,"twenty":-17.08023,"median":-16.682773,"eighty":-16.455087,"marketCap":10384358920},{"date":"2022-12-09","current":-16.284129,"twenty":-17.029868,"median":-16.675441,"eighty":-16.360668,"marketCap":10364388999},{"date":"2022-12-16","current":-16.102056,"twenty":-17.016962,"median":-16.650632,"eighty":-16.338699,"marketCap":10224599552},{"date":"2022-12-23","current":-16.065604,"twenty":-16.984778,"median":-16.637147,"eighty":-16.314572,"marketCap":10204629631},{"date":"2022-12-30","current":-15.934887,"twenty":-16.966494,"median":-16.614292,"eighty":-16.270012,"marketCap":10244569473},{"date":"2023-01-06","current":-15.64986,"twenty":-16.949062,"median":-16.590059,"eighty":-16.212217,"marketCap":10164689789},{"date":"2023-01-13","current":-15.537191,"twenty":-16.938757,"median":-16.549025,"eighty":-16.179981,"marketCap":10284509315},{"date":"2023-01-20","current":-15.580379,"twenty":-16.925026,"median":-16.534664,"eighty":-16.156179,"marketCap":10224599552},{"date":"2023-01-27","current":-15.546768,"twenty":-16.914539,"median":-16.533948,"eighty":-16.10098,"marketCap":10204629631},{"date":"2023-02-03","current":-15.436408,"twenty":-16.898489,"median":-16.443424,"eighty":-15.899534,"marketCap":10184659710},{"date":"2023-02-10","current":-15.407922,"twenty":-16.85946,"median":-16.367528,"eighty":-15.72674,"marketCap":10104780026},{"date":"2023-02-17","current":-15.462828,"twenty":-16.826005,"median":-16.357582,"eighty":-15.576487,"marketCap":10044870263},{"date":"2023-02-24","current":-15.747577,"twenty":-16.809749,"median":-16.341273,"eighty":-15.581234,"marketCap":10104780026},{"date":"2023-03-03","current":-16.543432,"twenty":-16.800921,"median":-16.334837,"eighty":-15.597252,"marketCap":10683907735},{"date":"2023-03-10","current":-15.544967,"twenty":-15.579303,"median":-15.560593,"eighty":-15.545027,"marketCap":9964990579},{"date":"2023-03-17","current":-15.303442,"twenty":-16.772422,"median":-16.316556,"eighty":-15.545905,"marketCap":9905080816},{"date":"2023-03-24","current":-15.373763,"twenty":-16.756627,"median":-16.272365,"eighty":-15.544864,"marketCap":10064840184},{"date":"2023-03-31","current":-14.490947,"twenty":-16.750261,"median":-16.244078,"eighty":-15.503171,"marketCap":9964990579},{"date":"2023-04-06","current":-14.616535,"twenty":-16.74805,"median":-16.201654,"eighty":-15.47105,"marketCap":10044870263},{"date":"2023-04-14","current":-14.718236,"twenty":-16.746563,"median":-16.189978,"eighty":-15.435882,"marketCap":10124749947},{"date":"2023-04-21","current":-14.522496,"twenty":-16.716504,"median":-16.166943,"eighty":-15.404922,"marketCap":9984960500},{"date":"2023-04-28","current":-14.543652,"twenty":-16.690584,"median":-16.159298,"eighty":-15.375204,"marketCap":9925050737},{"date":"2023-05-05","current":-14.549057,"twenty":-16.684047,"median":-16.100712,"eighty":-15.342097,"marketCap":9945020658},{"date":"2023-05-12","current":-14.620521,"twenty":-16.678887,"median":-16.039544,"eighty":-15.333905,"marketCap":9925050737},{"date":"2023-05-19","current":-14.943491,"twenty":-16.675965,"median":-15.890696,"eighty":-15.23178,"marketCap":9725351527},{"date":"2023-05-25","current":-14.912803,"twenty":-16.675501,"median":-15.809962,"eighty":-15.067549,"marketCap":9665441764},{"date":"2023-06-02","current":-14.437965,"twenty":-16.668929,"median":-15.747577,"eighty":-14.987375,"marketCap":9325953107},{"date":"2023-06-09","current":-14.613629,"twenty":-16.656022,"median":-15.667464,"eighty":-14.759824,"marketCap":9425802712},{"date":"2023-06-16","current":-13.688431,"twenty":-16.648221,"median":-15.639948,"eighty":-14.693346,"marketCap":8786765240},{"date":"2023-06-23","current":-13.012764,"twenty":-16.643191,"median":-15.607551,"eighty":-14.659979,"marketCap":8307487136},{"date":"2023-06-30","current":-13.257814,"twenty":-16.637379,"median":-15.582942,"eighty":-14.61421,"marketCap":8387366820},{"date":"2023-07-07","current":-12.682797,"twenty":-16.632266,"median":-15.576118,"eighty":-14.550185,"marketCap":8007938321},{"date":"2023-07-14","current":-12.819193,"twenty":-16.613957,"median":-15.551683,"eighty":-14.529885,"marketCap":8207637531},{"date":"2023-07-21","current":-12.973057,"twenty":-16.608106,"median":-15.545068,"eighty":-14.516129,"marketCap":8267547294},{"date":"2023-07-28","current":-12.535237,"twenty":-16.582609,"median":-15.540993,"eighty":-14.488236,"marketCap":7979980431},{"date":"2023-08-04","current":-11.938194,"twenty":-16.552097,"median":-15.522734,"eighty":-14.412097,"marketCap":7612533885},{"date":"2023-08-11","current":-10.431222,"twenty":-16.549158,"median":-15.479965,"eighty":-14.353579,"marketCap":6614037835},{"date":"2023-08-18","current":-9.656286,"twenty":-16.54773,"median":-15.439162,"eighty":-14.141185,"marketCap":6078843952},{"date":"2023-08-25","current":-10.146146,"twenty":-16.543346,"median":-15.430512,"eighty":-13.53248,"marketCap":6390374720},{"date":"2023-09-01","current":-12.99564,"twenty":-16.541336,"median":-15.407922,"eighty":-13.291047,"marketCap":7293015149},{"date":"2023-09-08","current":-12.315048,"twenty":-16.534521,"median":-15.387742,"eighty":-12.99529,"marketCap":6829712982},{"date":"2023-09-15","current":-10.219312,"twenty":-16.520569,"median":-15.373763,"eighty":-12.96537,"marketCap":5711397406},{"date":"2023-09-22","current":-10.063213,"twenty":-16.466215,"median":-15.341727,"eighty":-12.868104,"marketCap":5599565848},{"date":"2023-09-29","current":-11.178127,"twenty":-16.455087,"median":-15.334187,"eighty":-12.79424,"marketCap":6230615352},{"date":"2023-10-06","current":-9.993446,"twenty":-16.423987,"median":-15.333905,"eighty":-12.692866,"marketCap":5567613974},{"date":"2023-10-13","current":-9.290433,"twenty":-16.36975,"median":-15.303888,"eighty":-12.547785,"marketCap":5168215554},{"date":"2023-10-20","current":-8.010443,"twenty":-16.367528,"median":-15.102694,"eighty":-12.48935,"marketCap":4449298398},{"date":"2023-10-27","current":-8.488672,"twenty":-16.362478,"median":-15.063511,"eighty":-12.292711,"marketCap":4712901356},{"date":"2023-11-03","current":-8.710133,"twenty":-16.359022,"median":-15.056757,"eighty":-12.104621,"marketCap":4848696818},{"date":"2023-11-10","current":-8.898536,"twenty":-16.357046,"median":-14.912803,"eighty":-11.941145,"marketCap":4952540408},{"date":"2023-11-17","current":-8.747876,"twenty":-16.349399,"median":-14.761097,"eighty":-11.58475,"marketCap":4912600566},{"date":"2023-11-24","current":-9.071472,"twenty":-16.342534,"median":-14.718236,"eighty":-10.82373,"marketCap":5136263681},{"date":"2023-12-01","current":-8.640618,"twenty":-16.330975,"median":-14.677453,"eighty":-10.271499,"marketCap":4912600566},{"date":"2023-12-08","current":-7.758741,"twenty":-16.322161,"median":-14.658546,"eighty":-10.157974,"marketCap":4393382620},{"date":"2023-12-15","current":-7.349523,"twenty":-16.318638,"median":-14.616817,"eighty":-10.062883,"marketCap":4185695441},{"date":"2023-12-22","current":-8.126371,"twenty":-16.317676,"median":-14.584545,"eighty":-9.957278,"marketCap":4625033703},{"date":"2023-12-29","current":-8.362487,"twenty":-16.317157,"median":-14.562072,"eighty":-9.871741,"marketCap":4784793071},{"date":"2024-01-05","current":-7.803247,"twenty":-16.314572,"median":-14.547516,"eighty":-9.761569,"marketCap":4433322462},{"date":"2024-01-12","current":-7.461837,"twenty":-16.302134,"median":-14.536365,"eighty":-9.504477,"marketCap":4241611220},{"date":"2024-01-19","current":-7.035876,"twenty":-16.279423,"median":-14.522365,"eighty":-9.33176,"marketCap":3993984200},{"date":"2024-01-26","current":-6.794958,"twenty":-16.258464,"median":-14.515165,"eighty":-9.235745,"marketCap":3842212800},{"date":"2024-02-02","current":-6.280276,"twenty":-16.248749,"median":-14.494808,"eighty":-9.119832,"marketCap":3546657969},{"date":"2024-02-09","current":-6.080594,"twenty":-16.236113,"median":-14.46742,"eighty":-9.04289,"marketCap":3450802348},{"date":"2024-02-16","current":-6.100388,"twenty":-16.212217,"median":-14.448798,"eighty":-8.990936,"marketCap":3462784301},{"date":"2024-02-23","current":-5.580985,"twenty":-16.200095,"median":-14.377271,"eighty":-8.779882,"marketCap":3151253533},{"date":"2024-03-01","current":-6.821664,"twenty":-16.194567,"median":-14.359409,"eighty":-8.66879,"marketCap":3854194753},{"date":"2024-03-08","current":-6.691446,"twenty":-16.187898,"median":-14.283383,"eighty":-8.531038,"marketCap":3782303037},{"date":"2024-03-15","current":-7.256077,"twenty":-16.179981,"median":-13.930623,"eighty":-8.39945,"marketCap":4097827789},{"date":"2024-03-22","current":-6.151369,"twenty":-16.169224,"median":-13.579636,"eighty":-8.326104,"marketCap":3470772269},{"date":"2024-03-28","current":-8.333872,"twenty":-16.165922,"median":-13.45297,"eighty":-8.269405,"marketCap":3454796333},{"date":"2024-04-05","current":-6.804027,"twenty":-16.165092,"median":-13.428292,"eighty":-8.136639,"marketCap":2819752845},{"date":"2024-04-12","current":-6.357095,"twenty":-16.162416,"median":-13.25289,"eighty":-8.013058,"marketCap":2636029572},{"date":"2024-04-19","current":-7.133743,"twenty":-16.143691,"median":-12.995421,"eighty":-7.920902,"marketCap":2955548308},{"date":"2024-04-26","current":-8.011238,"twenty":-16.101518,"median":-12.982283,"eighty":-7.901825,"marketCap":3315006886},{"date":"2024-05-03","current":-8.4804,"twenty":-16.099367,"median":-12.963448,"eighty":-7.90259,"marketCap":3506718127},{"date":"2024-05-10","current":-9.394996,"twenty":-16.065604,"median":-12.898932,"eighty":-7.913843,"marketCap":3894134595},{"date":"2024-05-17","current":-9.215805,"twenty":-16.044756,"median":-12.867532,"eighty":-7.919339,"marketCap":3814254911},{"date":"2024-05-24","current":-9.246573,"twenty":-15.983649,"median":-12.819193,"eighty":-7.921471,"marketCap":3818248895},{"date":"2024-05-31","current":-8.589796,"twenty":-15.941845,"median":-12.752108,"eighty":-7.961158,"marketCap":3550651953},{"date":"2024-06-07","current":-7.768472,"twenty":-15.864181,"median":-12.691034,"eighty":-7.961158,"marketCap":3207169312},{"date":"2024-06-14","current":-7.814329,"twenty":-15.826431,"median":-12.62649,"eighty":-7.909342,"marketCap":3223145249},{"date":"2024-06-21","current":-7.277623,"twenty":-15.809345,"median":-12.53142,"eighty":-7.79631,"marketCap":2995488150},{"date":"2024-06-28","current":-7.426256,"twenty":-15.789546,"median":-12.48935,"eighty":-7.753383,"marketCap":3055397913},{"date":"2024-07-05","current":-7.495836,"twenty":-15.765827,"median":-12.315048,"eighty":-7.684126,"marketCap":3083355802},{"date":"2024-07-12","current":-7.223066,"twenty":-15.726554,"median":-12.278434,"eighty":-7.629416,"marketCap":2975518229},{"date":"2024-07-19","current":-7.193846,"twenty":-15.685816,"median":-12.106939,"eighty":-7.601973,"marketCap":2963536276},{"date":"2024-07-26","current":-6.703571,"twenty":-15.668373,"median":-11.984006,"eighty":-7.505156,"marketCap":2771825034},{"date":"2024-08-02","current":-6.523845,"twenty":-15.657694,"median":-11.938194,"eighty":-7.459727,"marketCap":2695939335},{"date":"2024-08-09","current":-5.9622,"twenty":-15.645895,"median":-11.636139,"eighty":-7.412301,"marketCap":2480264188},{"date":"2024-08-16","current":-6.420552,"twenty":-15.638291,"median":-11.199705,"eighty":-7.36919,"marketCap":2671975429},{"date":"2024-08-23","current":-6.211949,"twenty":-15.624504,"median":-10.786048,"eighty":-7.29332,"marketCap":2596089730},{"date":"2024-08-30","current":-9.587395,"twenty":-15.607156,"median":-10.431222,"eighty":-7.274264,"marketCap":2568131840},{"date":"2024-09-06","current":-9.344329,"twenty":-15.59757,"median":-10.232292,"eighty":-7.282379,"marketCap":2504228093},{"date":"2024-09-13","current":-8.935525,"twenty":-15.58317,"median":-10.160931,"eighty":-7.29332,"marketCap":2388402551},{"date":"2024-09-20","current":-9.357565,"twenty":-15.581519,"median":-10.098938,"eighty":-7.308194,"marketCap":2516210046},{"date":"2024-09-27","current":-10.320372,"twenty":-15.579527,"median":-10.073832,"eighty":-7.345779,"marketCap":2791794955},{"date":"2024-10-04","current":-14.698364,"twenty":-15.576118,"median":-10.122542,"eighty":-7.349523,"marketCap":3958038342},{"date":"2024-10-10","current":-11.132217,"twenty":-15.571743,"median":-10.161683,"eighty":-7.362761,"marketCap":2979512213},{"date":"2024-10-18","current":-10.459714,"twenty":-15.559408,"median":-10.219312,"eighty":-7.372309,"marketCap":2783806987},{"date":"2024-10-25","current":-10.340316,"twenty":-15.548734,"median":-10.261664,"eighty":-7.392688,"marketCap":2751855113},{"date":"2024-11-01","current":-9.358506,"twenty":-15.545617,"median":-10.176873,"eighty":-7.401158,"marketCap":2492246140},{"date":"2024-11-08","current":-9.082377,"twenty":-15.54512,"median":-10.153538,"eighty":-7.405713,"marketCap":2400384504},{"date":"2024-11-15","current":-9.288588,"twenty":-15.544987,"median":-10.084452,"eighty":-7.417986,"marketCap":2436330362},{"date":"2024-11-22","current":-8.63879,"twenty":-15.54483,"median":-10.062389,"eighty":-7.42517,"marketCap":2264589041},{"date":"2024-11-29","current":-8.902865,"twenty":-15.538712,"median":-9.993446,"eighty":-7.43744,"marketCap":2332486772},{"date":"2024-12-06","current":-9.336462,"twenty":-15.534727,"median":-9.926941,"eighty":-7.454703,"marketCap":2440324346},{"date":"2024-12-13","current":-12.12859,"twenty":-15.525009,"median":-9.993446,"eighty":-7.461134,"marketCap":3167229470},{"date":"2024-12-20","current":-12.949109,"twenty":-15.49665,"median":-10.062389,"eighty":-7.463103,"marketCap":3362934696},{"date":"2024-12-27","current":-13.005336,"twenty":-15.48963,"median":-10.080954,"eighty":-7.464331,"marketCap":3374916649},{"date":"2025-01-03","current":-12.469835,"twenty":-15.485315,"median":-10.098938,"eighty":-7.471726,"marketCap":3239121186},{"date":"2025-01-10","current":-11.884455,"twenty":-15.469406,"median":-10.153538,"eighty":-7.500496,"marketCap":3075367834},{"date":"2025-01-17","current":-11.658965,"twenty":-15.458095,"median":-10.176873,"eighty":-7.522658,"marketCap":3019452055},{"date":"2025-01-24","current":-12.076794,"twenty":-15.438611,"median":-10.261664,"eighty":-7.541025,"marketCap":3147259549},{"date":"2025-01-28","current":-12.004152,"twenty":-15.43751,"median":-10.281809,"eighty":-7.549574,"marketCap":3143265565},{"date":"2025-02-07","current":-11.806203,"twenty":-15.434831,"median":-10.340316,"eighty":-7.578575,"marketCap":3075367834},{"date":"2025-02-14","current":-12.541461,"twenty":-15.429859,"median":-10.454096,"eighty":-7.606855,"marketCap":3259091107},{"date":"2025-02-21","current":-13.329047,"twenty":-15.417717,"median":-10.628219,"eighty":-7.62064,"marketCap":3482754222},{"date":"2025-02-28","current":-14.093919,"twenty":-15.409299,"median":-10.676284,"eighty":-7.632465,"marketCap":3670471479},{"date":"2025-03-07","current":-18.299233,"twenty":-15.417717,"median":-10.848852,"eighty":-7.647988,"marketCap":4784793071},{"date":"2025-03-14","current":-20.796737,"twenty":-15.448628,"median":-11.155172,"eighty":-7.670492,"marketCap":5439806480},{"date":"2025-03-21","current":-24.073812,"twenty":-15.503171,"median":-11.213505,"eighty":-7.682665,"marketCap":6294519099},{"date":"2025-03-28","current":166.890984,"twenty":-15.535343,"median":-11.265741,"eighty":-7.670492,"marketCap":5990976300},{"date":"2025-04-03","current":148.592565,"twenty":-15.52956,"median":-11.188916,"eighty":-7.619299,"marketCap":5335962891},{"date":"2025-04-11","current":137.813994,"twenty":-15.509692,"median":-11.08181,"eighty":-7.526181,"marketCap":4904612597},{"date":"2025-04-17","current":132.251881,"twenty":-15.489879,"median":-10.723244,"eighty":-7.463876,"marketCap":4712901356},{"date":"2025-04-25","current":130.653866,"twenty":-15.488881,"median":-10.665186,"eighty":-7.440236,"marketCap":4664973545},{"date":"2025-05-02","current":155.157263,"twenty":-15.474616,"median":-10.628219,"eighty":-7.405713,"marketCap":5551638038},{"date":"2025-05-09","current":134.566778,"twenty":-15.466117,"median":-10.459714,"eighty":-7.370749,"marketCap":4848696818},{"date":"2025-05-16","current":132.156923,"twenty":-15.448628,"median":-10.385769,"eighty":-7.295224,"marketCap":4800769008},{"date":"2025-05-23","current":176.26836,"twenty":-15.43751,"median":-10.285563,"eighty":-7.262732,"marketCap":6422326593},{"date":"2025-05-30","current":194.268841,"twenty":-15.434831,"median":-10.232292,"eighty":-7.240227,"marketCap":7109291876},{"date":"2025-06-06","current":190.508609,"twenty":-15.429859,"median":-10.162435,"eighty":-7.194033,"marketCap":6989472350},{"date":"2025-06-13","current":242.122352,"twenty":-15.417717,"median":-10.132322,"eighty":-7.161917,"marketCap":8886614845},{"date":"2025-06-20","current":239.872041,"twenty":-15.409299,"median":-10.084452,"eighty":-7.088113,"marketCap":8786765240},{"date":"2025-06-27","current":246.269522,"twenty":-15.398923,"median":-10.062389,"eighty":-7.044514,"marketCap":9046374213},{"date":"2025-07-04","current":250.063256,"twenty":-15.391199,"median":-10.003136,"eighty":-7.007459,"marketCap":9186163660},{"date":"2025-07-11","current":230.181341,"twenty":-15.387916,"median":-9.934047,"eighty":-6.832291,"marketCap":8447276583},{"date":"2025-07-18","current":234.173998,"twenty":-15.382348,"median":-9.913676,"eighty":-6.798586,"marketCap":8587066030},{"date":"2025-07-25","current":225.72884,"twenty":-15.374844,"median":-9.853307,"eighty":-6.692805,"marketCap":8307487136},{"date":"2025-08-01","current":277.909452,"twenty":-15.373763,"median":-9.815898,"eighty":-6.59652,"marketCap":10164689789},{"date":"2025-08-08","current":261.421777,"twenty":-15.361688,"median":-9.735143,"eighty":-6.513228,"marketCap":9585562080},{"date":"2025-08-15","current":268.795789,"twenty":-15.342097,"median":-9.631387,"eighty":-6.417235,"marketCap":9841177068},{"date":"2025-08-22","current":273.580909,"twenty":-15.337645,"median":-9.532105,"eighty":-6.350598,"marketCap":9984960500},{"date":"2025-08-29","current":62.555475,"twenty":-15.334252,"median":-9.483572,"eighty":-6.272638,"marketCap":9042380228},{"date":"2025-09-05","current":69.200112,"twenty":-15.334074,"median":-9.453998,"eighty":-6.171457,"marketCap":9992948468},{"date":"2025-09-12","current":63.498906,"twenty":-15.333905,"median":-9.423977,"eighty":-6.10359,"marketCap":9186163660},{"date":"2025-09-19","current":75.976522,"twenty":-15.323094,"median":-9.37227,"eighty":-6.060838,"marketCap":10983456550},{"date":"2025-09-26","current":79.221129,"twenty":-15.305861,"median":-9.358035,"eighty":-6.019236,"marketCap":11422794812},{"date":"2025-10-03","current":75.937529,"twenty":-15.304156,"median":-9.345758,"eighty":-5.969828,"marketCap":10975468581},{"date":"2025-10-10","current":69.406568,"twenty":-15.303442,"median":-9.33177,"eighty":-5.941754,"marketCap":10016912373},{"date":"2025-10-17","current":63.035254,"twenty":-15.124286,"median":-9.321633,"eighty":-5.913943,"marketCap":9090308039},{"date":"2025-10-20","current":65.957163,"twenty":-15.119968,"median":-9.315346,"eighty":-5.897815,"marketCap":9505682396}],"updateTime":1761021446790},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02315\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2570050750","title":"百奧賽圖IPO過會:半年營收6.2億擬募資12億 沈月雷控制27%投票權","url":"https://stock-news.laohu8.com/highlight/detail?id=2570050750","media":"雷递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570050750?lang=zh_tw&edition=fundamental","pubTime":"2025-09-24 23:54","pubTimestamp":1758729255,"startTime":"0","endTime":"0","summary":"百奥赛图2025年上半年营收为6.21亿元,较上年同期的4.1亿元增长51.27%;净利为4800万元,上年同期为净亏损5067万元;扣非后净利为2855万元,上年同期的扣非后净亏损为5540万元。沈月雷夫妇控制27%投票权此次冲刺科创板前,百奥赛图已于2022年9月在港交所上市,成为基因编辑第一股,发行价为25.22港元,募资净额为4.71亿港元。截至本招股说明书签署日,沈月雷直接持有百奥赛图6.6086%股份,倪健直接持有百奥赛图7.2621%股份。沈月雷与倪健系夫妻关系。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924235722a44178cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924235722a44178cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2569707801","title":"百奧賽圖-B(02315)建議A股發行獲上交所科創板上市委員會批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2569707801","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569707801?lang=zh_tw&edition=fundamental","pubTime":"2025-09-24 21:43","pubTimestamp":1758721412,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百奥赛图-B(02315)公布,上交所科创板上市委员会2025年第38次审议会议已于 2025年9月24日召开。根据会议审议结果,公司建议A股发行及于上交所科创板上市已获上交所科创板上市委员会批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349087.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02315","159982","399300","BK1161"],"gpt_icon":0},{"id":"2570605073","title":"百奧賽圖科創板過會!「模式動物三巨頭」或將齊聚A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2570605073","media":"大河财立方","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570605073?lang=zh_tw&edition=fundamental","pubTime":"2025-09-24 20:47","pubTimestamp":1758718070,"startTime":"0","endTime":"0","summary":"业务方面,百奥赛图主要包括基因编辑、抗体开发、模式动物销售和临床前药效评价四大板块。百奥赛图称,已在2023年第三季度前基本完成该计划的主体工作。“模式动物三巨头”将齐聚A股,市场发展前景广阔除百奥赛图外,南模生物和药康生物也是国内模式动物市场的领先企业,三者并称为“模式动物三巨头”。百奥赛图此次成功过会,意味着这三家企业有望齐聚登陆A股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924204826a441257b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924204826a441257b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2570202050","title":"百奧賽圖科創板IPO過會 從「實驗小鼠」到佈局全產業鏈","url":"https://stock-news.laohu8.com/highlight/detail?id=2570202050","media":"e公司","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570202050?lang=zh_tw&edition=fundamental","pubTime":"2025-09-24 19:29","pubTimestamp":1758713340,"startTime":"0","endTime":"0","summary":"2022年9月登陆港股的百奥赛图(北京)医药科技股份有限公司即将回A,实现A+H上市。9月24日,上交所上市审核委员会召开2025年第38次上市审核委员会审议会议,审议百奥赛图首发事项,最终公司顺利过会。百奥赛图成立于2009年,是一家临床前CRO以及生物技术企业。依托于抗体药物发现平台的领先优势,百奥赛图通过RenMice小鼠授权以及“千鼠万抗”的形式展开抗体对外合作开发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924193037a440ff5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924193037a440ff5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2570050713","title":"H+A淨利潤2300萬的CRO公司,科創板過會!","url":"https://stock-news.laohu8.com/highlight/detail?id=2570050713","media":"和诚咨询","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570050713?lang=zh_tw&edition=fundamental","pubTime":"2025-09-24 18:18","pubTimestamp":1758709080,"startTime":"0","endTime":"0","summary":"一:主营业务发行人成立于 2009 年,是一家临床前 CRO 以及生物技术企业。公司已累计为全球近 900 名合作伙伴完成了超过 5,300 个药物评估项目,并协助部分合作伙伴成功完成了 IND 申报工作。截至本招股说明书签署之日,发行人及其子公司共拥有 192 项对主营业务有重大影响的发明专利,其中境内专利 97 项,境外专利 95 项。二:控股股东及实际控制人截至本招股说明书签署日,沈月雷直接持有发行人 6.6086%股份,倪健直接持有发行人 7.2621%股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924200235a69b4964&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924200235a69b4964&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","02315","BK1161","BK1574","09939"],"gpt_icon":0},{"id":"2569628796","title":"百奧賽圖:從「千鼠萬抗」到全球合作,中國Biotech的出海範本","url":"https://stock-news.laohu8.com/highlight/detail?id=2569628796","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569628796?lang=zh_tw&edition=fundamental","pubTime":"2025-09-23 17:34","pubTimestamp":1758620040,"startTime":"0","endTime":"0","summary":"在抗体偶联药物热度持续攀升的当下,全球生物医药产业链迎来新一轮重塑。据弗若斯特沙利文预测,到2030年全球ADC外包服务市场规模将达到110亿美元,2022年至2030年的复合年增长率高达28.4%。 在这条高景气赛道上,国内Biotech正逐步走向全球舞台。百奥赛图便是其中的代表。随着海外合作不断拓展、抗体货架持续放量,公司正在成为中国Biotech出海的典型样本,也为全球新药研发提供了来自东方的创新引擎。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/enterprise/hk/2025-09-23/doc-infrnqyp7508791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ADC","BK4080","02315","BK1161","BK4231"],"gpt_icon":0},{"id":"2569761447","title":"H股上市後股價暴跌八成,百奧賽圖迎來科創板IPO大考","url":"https://stock-news.laohu8.com/highlight/detail?id=2569761447","media":"中金在线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569761447?lang=zh_tw&edition=fundamental","pubTime":"2025-09-23 11:05","pubTimestamp":1758596732,"startTime":"0","endTime":"0","summary":"2024年9月24日,百奥赛图将迎来科创板 IPO 上会审议。然而,梳理其招股书与公开信息发现,其盈利改善主要依靠压缩研发投入,实控人债务高企,H股上市后股价一度暴跌近八成。此次重启科创板 IPO,百奥赛图计划募资 11.85 亿元人民币,虽较最初申报的 18.93 亿元人民币有所缩水,但仍高于港股 IPO 的 5.37 亿港元。股权结构方面,目前沈月雷、倪健夫妇合计控制公司 27.0% 的表决权,若科创板上市成功,股权预计稀释至 21.6%,低于 30% 的相对控股安全线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092311203597a3bd36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092311203597a3bd36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSTECH","02315","BK1161","HSCEI"],"gpt_icon":1},{"id":"2569261761","title":"百奧賽圖-B盤中異動 早盤股價大跌5.04%報26.020港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2569261761","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569261761?lang=zh_tw&edition=fundamental","pubTime":"2025-09-23 10:02","pubTimestamp":1758592967,"startTime":"0","endTime":"0","summary":"2025年09月23日早盘10时02分,百奥赛图-B股票出现异动,股价大幅跳水5.04%。截至发稿,该股报26.020港元/股,成交量4.4万股,换手率0.04%,振幅5.26%。百奥赛图-B股票所在的生物技术行业中,整体涨幅为0.29%。据悉,百奥赛图成立于2009年,是一家临床前CRO以及生物技术企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923100248a43d84f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923100248a43d84f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2569216761","title":"\"A+H雙市套利\"背後的困惑:百奧賽圖募資初衷與上市規劃,為何難逃業界的深層質疑?","url":"https://stock-news.laohu8.com/highlight/detail?id=2569216761","media":"中金在线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569216761?lang=zh_tw&edition=fundamental","pubTime":"2025-09-23 09:34","pubTimestamp":1758591279,"startTime":"0","endTime":"0","summary":"“重基建,轻研发”争议百奥赛图A股的IPO于2023年6月20日获受理。百奥赛图的募资计划虽然符合科创板“支持研发基础设施建设”的导向,但其资金用途的结构比例仍存在值得商榷之处。而百奥赛图同期研发费用从 6.99 亿元降至 3.24 亿元,年均降幅 28.7%,研发费","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923101859a7307cf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923101859a7307cf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSCEI","HSTECH","BK1161","02315"],"gpt_icon":1},{"id":"2569876126","title":"百奧賽圖—IPO反饋問題","url":"https://stock-news.laohu8.com/highlight/detail?id=2569876126","media":"中金在线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569876126?lang=zh_tw&edition=fundamental","pubTime":"2025-09-23 09:08","pubTimestamp":1758589696,"startTime":"0","endTime":"0","summary":"截至2023年6月30日,多玛医药员工总人数11人,其中研发人员7人,累计研发投入约为1亿元,主要用于思道医药、多玛医药引进抗体分子支出以及委托外部独立第三方CRO企业进行药物研发两方面。2022年5月31日,多玛医药由发行人全资子公司变更为参股公司,此前,多玛医药未实际开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092309204397a37ccd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092309204397a37ccd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","09939","BK1515","LU1969619763.USD","09995","02315","LU2328871848.SGD","BK1583"],"gpt_icon":0},{"id":"2569575343","title":"H+A的百奧賽圖募資的隨意性與對科研人員卸磨殺驢來美化報表?","url":"https://stock-news.laohu8.com/highlight/detail?id=2569575343","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569575343?lang=zh_tw&edition=fundamental","pubTime":"2025-09-22 20:27","pubTimestamp":1758544070,"startTime":"0","endTime":"0","summary":"截至目前,百奥赛图在港股的市值约107亿港元,而这还是最近几个月涨上来的结果。03 费用调控“有妙招”,优化人员省大钱百奥赛图的费用变化堪称“神来之笔”。那些为项目付出心血的研发人员,转眼间就成了“卸磨杀驴”的对象。那么,百奥赛图给了这些被“优化”的员工多少补偿呢?百奥赛图的IPO之路,更像是一场精心计算的财务游戏:募资可以“随意砍”,盈利可以“优化”来,研发人员可以“耗材”化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092220404497a27012&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092220404497a27012&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2569423753","title":"百奧賽圖IPO:募資縮水超7億,要孖展11.85億,實控人外債不低","url":"https://stock-news.laohu8.com/highlight/detail?id=2569423753","media":"短平快解读","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569423753?lang=zh_tw&edition=fundamental","pubTime":"2025-09-22 20:20","pubTimestamp":1758543626,"startTime":"0","endTime":"0","summary":"实控人表决权不到30%。百奥赛图的控股股东、实际控制人均为沈月雷、倪健,两人系夫妻关系,截至招股书披露日,直接持股比例分别为6.61%、7.26%。募资缩水7.08亿元。百奥赛图表示,本案可能涉及的赔偿金额较小,公司具备相应支付能力,本案件预计不会对发行人生产经营或本次发行上市产生重大不利影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922210131a43c7da3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922210131a43c7da3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2569753442","title":"賣小鼠的百奧塞圖衝刺「A+H」,實控人夫婦竟「預製」股權質押?","url":"https://stock-news.laohu8.com/highlight/detail?id=2569753442","media":"银莕财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569753442?lang=zh_tw&edition=fundamental","pubTime":"2025-09-22 18:29","pubTimestamp":1758536983,"startTime":"0","endTime":"0","summary":"且与公司融资同步,百奥赛图实控人沈月雷、倪健夫妇亦很“缺钱”,在IPO排队期间,二人甚至通过“预制”股权质押方式获取大量借款。截至招股书签署日,沈月雷、倪健合计直接或间接控制公司27.0291%表决权。需要注意的是,百奥赛图实控人沈月雷、倪健夫妇同样缺钱。此后的借款还约定,若该次A股IPO未能成功,沈月雷/倪健则需将其持有的H股相应的股票质押给银行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922190746a72f423d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922190746a72f423d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2569753441","title":"百奧賽圖IPO:因專利侵權被起訴,獨董因信披違規被出具警示函","url":"https://stock-news.laohu8.com/highlight/detail?id=2569753441","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569753441?lang=zh_tw&edition=fundamental","pubTime":"2025-09-22 17:08","pubTimestamp":1758532097,"startTime":"0","endTime":"0","summary":"研发投入及人员逐年减少,专职研发人员仅个位数,因专利侵权被起诉在百奥赛图业绩增长的背后,公司的研发投入却呈现下降的趋势。此外,百奥赛图报告期内还因为专利侵权被告上了法庭。值得一提的是,百奥赛图的现任独立董事华风茂却因信披违规被证监会出具警示函。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922171901a43c0f55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922171901a43c0f55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2569075344","title":"百奧賽圖「雙業務線」持續放量:多項國際合作開啓新階段","url":"https://stock-news.laohu8.com/highlight/detail?id=2569075344","media":"新浪证券","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569075344?lang=zh_tw&edition=fundamental","pubTime":"2025-09-22 14:07","pubTimestamp":1758521220,"startTime":"0","endTime":"0","summary":"近期,百奥赛图在全球创新药产业链上的存在感愈发强烈。进入9月,公司接连发布三项合作消息,涵盖核酸药物递送、ADC研发与双抗ADC合作项目进展,充分展现了其“双业务线”战略的纵深布局与国际竞争力。这一项目代表了百奥赛图在双抗ADC领域的技术实力,也凸显了其在国际合作中的重要地位。在创新药产业进入组合化、精准化的趋势下,百奥赛图通过“双业务线”逻辑已成功实现从传统CRO到创新型平台企业的跨越。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092214071897a1b282&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092214071897a1b282&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":1},{"id":"2569753430","title":"錢燒光就回A?H股「基因編輯第一股」百奧賽圖帶着5個研發人員勇闖科創板IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2569753430","media":"中金在线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569753430?lang=zh_tw&edition=fundamental","pubTime":"2025-09-22 13:03","pubTimestamp":1758517396,"startTime":"0","endTime":"0","summary":"2025年港股市场上,百奥赛图的股价从年初8.50港元/股飙涨到27.50港元/股,涨幅达223.53%,头顶“基因编辑第一股”光环的它,将于9月24日上会审议,为冲击科创板实现A+H两地上市做关键一搏。后调整募资规模,直接砍掉7亿至 11.85 亿元,似乎为减少此次科创板IPO的阻力而为。2025年上半年,百奥赛图营收6.21亿元,净利润4800万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922131112a72e8d3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922131112a72e8d3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","09939","02315","BK1574","BK1161"],"gpt_icon":0},{"id":"2569753418","title":"百奧賽圖IPO:一面是A+H「光輝」,一面是大量人員「優化」,扭虧為盈的背後,心酸的「研發耗材」","url":"https://stock-news.laohu8.com/highlight/detail?id=2569753418","media":"中金在线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569753418?lang=zh_tw&edition=fundamental","pubTime":"2025-09-22 10:41","pubTimestamp":1758508887,"startTime":"0","endTime":"0","summary":"以上是基于现有招股说明书整理了百奥赛图的员工情况,从24年中间数来看,2024年,管理人员变动20%,研发人员变动率起码超过50%……2300万的辞退代价,换8600万的利润增量,还能实现“扭亏为盈”的里程碑意义,拥有一份好看的报表,和可以“畅想的未来”,确实是赚的","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922105108a43b5277&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922105108a43b5277&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2569534487","title":"IPO研究丨本週4家上會,「基因編輯第一股」回A待審","url":"https://stock-news.laohu8.com/highlight/detail?id=2569534487","media":"瑞财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569534487?lang=zh_tw&edition=fundamental","pubTime":"2025-09-22 09:39","pubTimestamp":1758505145,"startTime":"0","endTime":"0","summary":"瑞财经 吴文婷9月22日,据上交所、深交所、北交所,本周4家企业上会,1只新股将进行申购。世昌股份登陆北交所,在首日表现中,其大涨271.56%。其中,作为“基因编辑第一股”,百奥赛图成立于2009年,于2022年9月登陆港交所,是一家临床前CRO以及生物技术企业。另外,截止统计时间,IPO辅导备案增加2家,环比下降66.67%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922093926a72e2d2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922093926a72e2d2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2569775343","title":"今日1新股申購!格力、美的「小夥伴」將登陸北交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2569775343","media":"e公司","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569775343?lang=zh_tw&edition=fundamental","pubTime":"2025-09-22 07:50","pubTimestamp":1758498638,"startTime":"0","endTime":"0","summary":"据目前安排,若无变化,本周有1只新股申购。本次IPO,奥美森募资总额为1.9亿元,投入到金属管材数字化成型装备及其他订制类智能设备生产基地建设项目和研发中心建设项目。4公司IPO上会值得注意的是,截至目前本周将有4家公司IPO首发上会,为拟闯关科创板IPO的摩尔线程、百奥赛图;创业板IPO的南网数字以及北交所IPO的蘅东光。其中,9月26日科创板IPO上会的摩尔线程主要从事GPU及相关产品的研发、设计和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922075333a72dfe64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922075333a72dfe64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2568885257","title":"百奧賽圖-B09月19日主力淨流出0.7萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2568885257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568885257?lang=zh_tw&edition=fundamental","pubTime":"2025-09-19 16:16","pubTimestamp":1758269760,"startTime":"0","endTime":"0","summary":"09月19日, 百奥赛图-B股价跌0.15%,报收27.50元,成交金额1255.2万元,换手率0.42%,振幅4.94%,量比0.55。百奥赛图-B今日主力资金净流出0.7万元,上一交易日主力净流入42.8万元。该股近5个交易日上涨21.74%,主力资金累计净流出73.7万元;近20日主力资金累计净流出112.6万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919162417979cd785&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919162417979cd785&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":2,"totalSize":153,"code":"91000000","status":"200"}]}}